• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重症肌无力患者血浆置换过程中血清细胞因子水平的变化。

Changes in serum cytokine levels during plasmapheresis in patients with myasthenia gravis.

机构信息

Department of Neurology, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan.

出版信息

Eur J Neurol. 2009 Dec;16(12):1318-22. doi: 10.1111/j.1468-1331.2009.02729.x. Epub 2009 Jul 14.

DOI:10.1111/j.1468-1331.2009.02729.x
PMID:19614971
Abstract

BACKGROUND

The effect of plasmapheresis on cytokine levels in patients with myasthenia gravis (MG) has not been well established.

METHODS

Cytokine levels were measured in 19 patients with MG before and after treatment with one course of double-filtration plasmapheresis (DFP). The control group comprised 6 age- and sex-matched healthy volunteers.

RESULTS

At baseline, patients with MG had higher levels of IL-10 than normal controls. The levels of IL-2, IL-4, IL-5, and tumor necrosis factor-alpha were almost undetectable in MG patients. After a single session of DFP treatment, IL-10 levels were significantly increased. After three sessions, IL-10 levels were still higher than those at baseline. Elevated IL-10 level was significantly associated with use of immunosuppressant drugs, thymectomy, and good response to DFP treatment.

CONCLUSIONS

Interleukin-10 might play a crucial role in the pathogenesis and perpetuation of MG.

摘要

背景

血浆置换对重症肌无力(MG)患者细胞因子水平的影响尚未得到充分证实。

方法

19 例 MG 患者在接受一个疗程的双重滤过血浆置换(DFP)治疗前后,检测细胞因子水平。对照组由 6 名年龄和性别匹配的健康志愿者组成。

结果

MG 患者在基线时的 IL-10 水平高于正常对照组。MG 患者的 IL-2、IL-4、IL-5 和肿瘤坏死因子-α水平几乎检测不到。单次 DFP 治疗后,IL-10 水平显著升高。三次治疗后,IL-10 水平仍高于基线。升高的 IL-10 水平与免疫抑制剂药物的使用、胸腺切除术和 DFP 治疗的良好反应显著相关。

结论

白细胞介素 10 可能在 MG 的发病机制和持续存在中起关键作用。

相似文献

1
Changes in serum cytokine levels during plasmapheresis in patients with myasthenia gravis.重症肌无力患者血浆置换过程中血清细胞因子水平的变化。
Eur J Neurol. 2009 Dec;16(12):1318-22. doi: 10.1111/j.1468-1331.2009.02729.x. Epub 2009 Jul 14.
2
[Soluble adhesive molecules and cytokines in patients with myasthenia gravis treated with plasmapheresis].[血浆置换治疗的重症肌无力患者中的可溶性黏附分子与细胞因子]
Cas Lek Cesk. 1998 Nov 2;137(21):654-9.
3
A decrease in the percentage of CD3+ cells is correlated with clinical improvement during plasmapheresis in patients with myasthenia gravis.在重症肌无力患者的血浆置换过程中,CD3+细胞百分比的下降与临床改善相关。
Artif Organs. 2013 Feb;37(2):211-6. doi: 10.1111/j.1525-1594.2012.01531.x. Epub 2012 Sep 30.
4
Experience in the treatment of myasthenia gravis with double filtration plasmapheresis.双重过滤血浆置换治疗重症肌无力的经验
Chang Gung Med J. 2000 Feb;23(2):80-6.
5
Prethymectomy plasmapheresis in myasthenia gravis.重症肌无力胸腺切除术前的血浆置换
J Clin Apher. 2005 Dec;20(4):217-21. doi: 10.1002/jca.20061.
6
Double filtration plasmapheresis benefits myasthenia gravis patients through an immunomodulatory action.双重过滤血浆置换通过免疫调节作用使重症肌无力患者受益。
J Clin Neurosci. 2014 Sep;21(9):1570-4. doi: 10.1016/j.jocn.2013.11.046. Epub 2014 May 9.
7
MuSK antibody clearance during serial sessions of plasmapheresis for myasthenia gravis.重症肌无力患者在连续多次血浆置换治疗期间MuSK抗体的清除情况。
J Neurol Sci. 2007 Dec 15;263(1-2):191-3. doi: 10.1016/j.jns.2007.05.033. Epub 2007 Jun 28.
8
Effects of double filtration plasmapheresis on nocturnal respiratory function in myasthenic patients.双重滤过血浆置换对重症肌无力患者夜间呼吸功能的影响。
Artif Organs. 2013 Dec;37(12):1076-9. doi: 10.1111/aor.12128. Epub 2013 Jul 19.
9
Inhibition of peripheral blood natural killer cell cytotoxicity in patients with myasthenia gravis treated with plasmapheresis.血浆置换治疗重症肌无力患者外周血自然杀伤细胞细胞毒性抑制。
Eur J Neurol. 2011 Nov;18(11):1350-7. doi: 10.1111/j.1468-1331.2011.03424.x. Epub 2011 May 7.
10
[Clinical study of double filtration plasmapheresis for treatment of refractory myasthenia gravis].双重滤过血浆置换治疗难治性重症肌无力的临床研究
Nan Fang Yi Ke Da Xue Xue Bao. 2007 Mar;27(3):355-7.

引用本文的文献

1
Longitudinal Improvement in Respiratory Function Following Plasma Exchange in Patients with Severe Myasthenia Gravis.重症肌无力患者血浆置换后呼吸功能的纵向改善
Neurocrit Care. 2025 Apr 3. doi: 10.1007/s12028-025-02238-9.
2
Myasthenia Gravis Treatment: From Old Drugs to Innovative Therapies with a Glimpse into the Future.重症肌无力的治疗:从旧药物到创新疗法,展望未来。
CNS Drugs. 2024 Jan;38(1):15-32. doi: 10.1007/s40263-023-01059-8. Epub 2024 Jan 11.
3
Research priorities for therapeutic plasma exchange in critically ill patients.
重症患者治疗性血浆置换的研究重点
Intensive Care Med Exp. 2023 May 8;11(1):26. doi: 10.1186/s40635-023-00510-w.
4
Immunomodulatory Aspects of Therapeutic Plasma Exchange in Neurological Disorders-A Pilot Study.免疫调节在神经障碍治疗性血浆置换中的作用:一项初步研究。
Int J Mol Sci. 2023 Mar 31;24(7):6552. doi: 10.3390/ijms24076552.
5
Protocol of comparison of the effects of single plasma exchange and double filtration plasmapheresis on peripheral lymphocyte phenotypes in patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: a monocentric prospective study with single-case experimental design.比较单次血浆置换和双重滤过血浆置换对慢性炎症性脱髓鞘性多发神经病患者外周血淋巴细胞表型影响的方案:一项单中心前瞻性研究,采用单病例实验设计。
BMC Neurol. 2022 Aug 5;22(1):293. doi: 10.1186/s12883-022-02816-w.
6
Lymphoplasma Exchange Improves Myasthenia Gravis Exacerbations: A Retrospective Study in a Chinese Center.淋巴浆细胞交换疗法改善重症肌无力恶化:中国中心的回顾性研究。
Front Immunol. 2022 Apr 14;13:757841. doi: 10.3389/fimmu.2022.757841. eCollection 2022.
7
Current Treatment of Myasthenia Gravis.重症肌无力的当前治疗方法
J Clin Med. 2022 Mar 14;11(6):1597. doi: 10.3390/jcm11061597.
8
TREATMENT OF MYASTHENIA GRAVIS PATIENTS WITH COVID-19: REVIEW OF THE LITERATURE.COVID-19 治疗重症肌无力患者:文献综述。
Acta Clin Croat. 2022 Feb;60(3):496-509. doi: 10.20471/acc.2021.60.03.21.
9
Therapeutic Plasma Exchange: For Cancer Patients.治疗性血浆置换:用于癌症患者。
Cancer Manag Res. 2022 Feb 2;14:411-425. doi: 10.2147/CMAR.S340472. eCollection 2022.
10
Case Report: Plasma Biomarkers Reflect Immune Mechanisms of Guillain-Barré Syndrome.病例报告:血浆生物标志物反映吉兰-巴雷综合征的免疫机制。
Front Neurol. 2021 Sep 3;12:720794. doi: 10.3389/fneur.2021.720794. eCollection 2021.